Dhampur Bio Organics Limited — Investor Meet, 09-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Dhampur Bio Organics reported FY’25 revenue at INR 2,714 Cr, up 15% YoY, led by sugar (+10%) and country liquor (+56%). EBITDA declined to INR 144 Cr and PAT dropped to INR 12 Cr from last year’s higher base. Q4 saw stronger performance with revenue at INR 702 Cr, EBITDA at INR 100 Cr, and PAT of INR 40 Cr. Sugar output fell to 3.1 lakh tons; ethanol volumes declined sharply, while country liquor sales surged. Management is prioritizing varietal replacement, better cane yields, and expanding country liquor via new grain distillery operations. Capex remains limited; debt rose slightly but is manageable. Outlook is cautious yet optimistic on recovery in coming seasons.